The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Veloxa Chewable Tablets for Dogs

50, 150, 50 mg/tablet Chewable tablet

LAVET Pharmaceuticals LtdVPA10482/002/001

Main Information

Trade NameVeloxa Chewable Tablets for Dogs
Active SubstancesPraziquantel
Strength50, 150, 50 mg/tablet
Dosage FormChewable tablet
Licence HolderLAVET Pharmaceuticals Ltd
Licence NumberVPA10482/002/001

Group Information

ATC CodeQP52AA51 praziquantel, combinations
Therapeutic ClassCardiovascular


Licence Issued18/01/2013
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back